Michael Cooreman
Company: Inventiva
Job title: Chief Medical Officer
Seminars:
The Potential of Pan-PPAR Agonist Therapy to Address Inflammation and Fibrosis in Patients with MASH – a Path to a Holistic Approach 11:15 am
Delving into the anti-fibrotic and anti-inflammatory impacts Assessing developments from Phase 3 trialsRead more
day: Conference Day 2 Track 2 AM